The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, compared to hydroxyurea to enhance NRTI antiviral activity in vivo

被引：0
|
作者：
Sumpter, R
Elford, H
Inayat, M
Sugg, T
Tsai, P
Gallicchio, V
机构：
[1] Mol Hlth Inc, Richmond, VA USA
[2] Univ Kentucky, Lexington, KY USA
来源：
ANTIVIRAL RESEARCH | 2003年 / 57卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
26
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 45 条
  • [31] Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates.
    Manfredini, S
    Augusti, A
    Durini, E
    Vertuani, S
    Nalin, F
    Verri, A
    Spadari, S
    Focher, F
    Solaroli, N
    De Clercq, E
    Balzarini, J
    Ferrone, M
    Pricl, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U11 - U11
  • [32] Computational Analysis of the Apoptotic Activity of a Small Library of Novel Substituted Hydroxy Ureas Designed as Potential Inhibitors of Ribonucleotide Reductase
    McCourt, Mary P.
    Greene, Robert S.
    Smith, Charles
    McClory, Haley
    Wirth, Christopher
    Sumbler, Brittany
    Emery, Michelle L.
    Leskiw, Brian D.
    Krause, Josef G.
    McGahan, Megan E.
    Vanio, Shawn
    Jordan, Michael
    Pericozzi, Angela
    Priefer, Ronny
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (07) : 580 - 584
  • [33] Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA
    Raichurkar, AV
    Kulkarni, VM
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) : 4419 - 4427
  • [34] DISRUPTION OF HERPES-SIMPLEX VIRUS RIBONUCLEOTIDE REDUCTASE QUATERNARY STRUCTURE BY PEPTIDE INHIBITORS AS A NOVEL-APPROACH TO ANTIVIRAL THERAPY
    MARCELLO, A
    PALU, G
    JOURNAL OF CHEMOTHERAPY, 1995, 7 (05) : 403 - 405
  • [35] Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo
    Duan, JM
    Liuzzi, M
    Paris, W
    Lambert, M
    Lawetz, C
    Moss, N
    Jaramillo, J
    Gauthier, J
    Déziel, R
    Cordingley, MG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1629 - 1635
  • [36] A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo
    Van Dycke, Jana
    Dai, Wenhao
    Stylianidou, Zoe
    Li, Jian
    Cuvry, Arno
    Roux, Emma
    Li, Bingqian
    Rymenants, Jasper
    Bervoets, Lindsey
    de Witte, Peter
    Liu, Hong
    Neyts, Johan
    Rocha-Pereira, Joana
    VIRUSES-BASEL, 2021, 13 (09):
  • [37] New Iminodiacetate -Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity
    Zaltariov, Mirela F.
    Hammerstad, Marta
    Arabshahi, Homayon J.
    Jovanovic, Katarina
    Richter, Klaus W.
    Cazacu, Maria
    Shova, Sergiu
    Balan, Mihaela
    Andersen, Niels H.
    Raduloyic, Singa
    Reynisson, Johannes
    Andersson, Kristoffer
    Arion, Vladimir B.
    INORGANIC CHEMISTRY, 2017, 56 (06) : 3532 - 3549
  • [38] Two novel low-toxicity ribonucleotide reductase inhibitors that enhance the production of Hb F and F-cells in human K562 cells.
    Iyamu, EW
    Adunyah, SA
    Elford, HL
    Asakura, T
    Horiuchi, K
    Turner, EA
    BLOOD, 1999, 94 (10) : 418A - 418A
  • [39] Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766):: in vitro and in vivo antiviral activity and mechanism of action
    Reefschlaeger, J
    Bender, W
    Hallenberger, S
    Weber, O
    Eckenberg, P
    Goldmann, S
    Haerter, M
    Buerger, I
    Trappe, J
    Herrington, JA
    Haebich, D
    Ruebsamen-Waigmann, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) : 757 - 767
  • [40] Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells
    Mauritz, R
    Bekkenk, MW
    Rots, MG
    Pieters, R
    Mini, E
    van Zantwijk, CH
    Veerman, AJP
    Peters, GJ
    Jansen, G
    CLINICAL CANCER RESEARCH, 1998, 4 (10) : 2399 - 2410
12345